http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013144683-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2013-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013144683-A |
| titleOfInvention | IRON BISGLICINATE CHELATE FOR USE IN TREATMENT OF ANEMIA |
| abstract | 1. Chelate of iron bisglycinate for use in the oral treatment of anemia in patients at the preoperative and / or postoperative stage of a surgical operation, characterized in that said surgical operation is an operation accompanied by profuse bleeding selected from surgery of the shoulder, hip, knee and / or joint spine. 2. The iron bisglycinate chelate for use according to claim 1, characterized in that the anemia is mild or moderate. Iron bisglycinate chelate for use according to any one of claims 1 to 2, characterized in that said anemia is sidepenic anemia. 4. Iron bisglycinate chelate for use according to claim 1 or 2, characterized in that said patient is an elderly patient. The iron bisglycinate chelate for use according to claim 4, characterized in that said patient is over 65 years old. The iron bisglycinate chelate for use according to claim 1, characterized in that said surgical operation accompanied by heavy bleeding is an orthopedic surgery. The iron bisglycinate chelate for use according to claim 6, characterized in that said intervention is an endoprosthesis replacement of all or part of the hip joint or all or part of the knee joint. The iron bisglycinate chelate for use according to claim 1, made in the form of a solid dosage form. The iron bisglycinate chelate for use according to claim 8, characterized in that said solid dosage form is selected from a tablet, granule, microgranule or capsule. Iron bisglycinate chelate for use according to claim 8 or 9, characterized in that said solid drug |
| priorityDate | 2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.